CytomX

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.

About CTMX

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. 

CEO
Sean A. McCarthy
CEOSean A. McCarthy
Employees
69
Employees69
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2010
Founded2010
Employees
69
Employees69

CTMX Key Statistics

Market cap
759.25M
Market cap759.25M
Price-Earnings ratio
-9.21
Price-Earnings ratio-9.21
Dividend yield
Dividend yield
Average volume
2.23M
Average volume2.23M
High today
$3.38
High today$3.38
Low today
$3.27
Low today$3.27
Open price
$3.33
Open price$3.33
Volume
2.03M
Volume2.03M
52 Week high
$8.21
52 Week high$8.21
52 Week low
$1.72
52 Week low$1.72

Stock Snapshot

The current CytomX(CTMX) stock price is $3.32, with a market capitalization of 759.25M. The stock trades at a price-to-earnings (P/E) ratio of -9.21.

During the trading session on 2026-08-05, CytomX(CTMX) shares reached a daily high of $3.38 and a low of $3.27. At a current price of $3.32, the stock is +1.6% higher than the low and still -1.6% under the high.

Trading volume for CytomX(CTMX) stock has reached 2.03M, versus its average volume of 2.23M.

The stock's 52-week range extends from a low of $1.72 to a high of $8.21.

The stock's 52-week range extends from a low of $1.72 to a high of $8.21.

CTMX News

TipRanks 3d
CytomX Therapeutics appoints Alejandra Carvajal as chief legal officer

CytomX Therapeutics (CTMX) announced the appointment of Alejandra Carvajal as chief legal officer. In this role, Carvajal will support the company’s strategic,...

Investing.com 4d
InvestingPro’s Fair Value predicted 46% drop in CytomX stock By Investing.com - Investing.com

...

InvestingPro’s Fair Value predicted 46% drop in CytomX stock By Investing.com - Investing.com

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CTMX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.